Bruker Corp. Stock
Price
Target price
€35.69
€35.69
0.250%
0.09
0.250%
€66.55
13:17 / Tradegate
WKN: 813534 / Symbol: BRKR / Name: Bruker / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Bruker Corp. Stock
Bruker Corp. gained 0.250% compared to yesterday.
We see a rather positive sentiment for Bruker Corp. with 15 Buy predictions and 1 Sell predictions.
With a target price of 66 € there is a hugely positive potential of 84.93% for Bruker Corp. compared to the current price of 35.69 €.
Our community identified positive and negative aspects for Bruker Corp. stock for the coming years. 0 users see the criterium "Revenue growth" as a plus for the Bruker Corp. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bruker Corp. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bruker Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 0.250% | 8.240% | 6.779% | -41.021% | -35.810% | - | - |
| Healthequity Inc. | -3.130% | 5.085% | 17.722% | 16.981% | 2.198% | 57.627% | 70.642% |
| Omnicell Inc. | -2.170% | 0.000% | 18.421% | -1.460% | -35.096% | -74.766% | -55.738% |
| Integer Hldg | - | 0.952% | 0.952% | -4.505% | -16.535% | 55.882% | 48.252% |
Comments
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at Barclays PLC from $50.00 to $46.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at Wells Fargo & Company from $75.00 to $60.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at Barclays PLC from $60.00 to $50.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat